Your browser doesn't support javascript.
loading
18F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial.
Quintela-Fandino, Miguel; Lluch, Ana; Manso, Luis; Calvo, Isabel; Cortes, Javier; García-Saenz, José Angel; Gil-Gil, Miguel; Martinez-Jánez, Noelia; Gonzalez-Martin, Antonio; Adrover, Encarna; de Andres, Raquel; Viñas, Gemma; Llombart-Cussac, Antonio; Alba, Emilio; Guerra, Juan; Bermejo, Begoña; Zamora, Esther; Moreno-Anton, Fernando; Pernas Simon, Sonia; Carrato, Alfredo; Lopez-Alonso, Antonio; Escudero, María José; Campo, Ruth; Carrasco, Eva; Palacios, José; Mulero, Francisca; Colomer, Ramon.
  • Quintela-Fandino M; Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, Madrid, Spain. mquintela@cnio.es.
  • Lluch A; Medical Oncology Department, Hospital Clinico Universitario, Valencia, Spain.
  • Manso L; Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain.
  • Calvo I; Medical Oncology Department, Hospital de Montepríncipe, Madrid, Spain.
  • Cortes J; Medical Oncology Department, Hospital Vall d'Hebron, Barcelona, Spain.
  • García-Saenz JA; Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain.
  • Gil-Gil M; Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain.
  • Martinez-Jánez N; Medical Oncology Department, Institut Catala d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Spain.
  • Gonzalez-Martin A; Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain.
  • Adrover E; Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain.
  • de Andres R; Medical Oncology Department, Hospital General de Albacete, Albacete, Spain.
  • Viñas G; Medical Oncology Department, Hospital Lozano Blesa, Zaragoza, Spain.
  • Llombart-Cussac A; Medical Oncology Department, Institut Catala d'Oncologia-Josep Trueta, Girona, Spain.
  • Alba E; Medical Oncology Department, Hospital Arnau de Vilanova, Valencia, Spain.
  • Guerra J; Medical Oncology Department, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain.
  • Bermejo B; Medical Oncology Department, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • Zamora E; Medical Oncology Department, Hospital Clinico Universitario, Valencia, Spain.
  • Moreno-Anton F; Medical Oncology Department, Hospital Vall d'Hebron, Barcelona, Spain.
  • Pernas Simon S; Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain.
  • Carrato A; Medical Oncology Department, Institut Catala d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Spain.
  • Lopez-Alonso A; Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain.
  • Escudero MJ; Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, Madrid, Spain.
  • Campo R; GEICAM, Madrid, Spain.
  • Carrasco E; GEICAM, Madrid, Spain.
  • Palacios J; GEICAM, Madrid, Spain.
  • Mulero F; Pathology Department, Hospital Ramon y Cajal, Madrid, Spain.
  • Colomer R; Molecular Imaging Unit, CNIO - Spanish National Cancer Research Center, Madrid, Spain.
Clin Cancer Res ; 23(6): 1432-1441, 2017 Mar 15.
Article en En | MEDLINE | ID: mdl-27587436
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Inhibidores de Proteínas Quinasas / Indoles Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Inhibidores de Proteínas Quinasas / Indoles Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2017 Tipo del documento: Article